Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > J Prev Med Public Health > Volume 41(2); 2008 > Article
English Abstract Guidelines for Economic Evaluation of Pharmaceuticals in Korea.
Eun Young Bae
Journal of Preventive Medicine and Public Health 2008;41(2):80-83
DOI: https://doi.org/10.3961/jpmph.2008.41.2.80
  • 5,266 Views
  • 85 Download
  • 13 Crossref
  • 14 Scopus
Department of Health Policy and Management, Sangji University, Korea. eybae@sanji.ac.kr
Full Article

Download PDF Download PDF

Abstract

An economic evaluation is required in order to apply to the Health Insurance Review and Assessment Service (HIRA) for a listing in the national drug formulary. To assist companies in preparing the necessary documents, HIRA published guidelines for the economic evaluation of pharmaceuticals in 2006. The guidelines are composed of two parts: guidance an explanatory notes. Each guideline reflects the best practice which meets both the theoretical consensus within the academic community and local situations, like data availability. To enhance the transparency of evaluation, guidelines emphasize the reproducibility of data and analysis result. That is, all evaluation processes are required to be described in enough detail to be replicated by reviewers. With growing experience and theoretical development in this area, HIRA guidelines will be revised periodically.

Related articles
JPMPH : Journal of Preventive Medicine and Public Health
© Korean Society for Preventive Medicine.